Dohmen will focus more closely on services to life sciences companies
Dohmen (Milwaukee), which over the years has gone from a major regional drug wholesaler, to a portfolio of service companies to pharma and payers, is exiting the pharmacy benefit management (PBM) business with the sale to Catamaran. The sale will close in the fourth quarter.
“We’ve decided to exit the pharmacy benefit management business so we can focus exclusively on our life science clients,” said Cynthia LaConte, Dohmen CEO. “Dohmen has a long history of anticipating transformative change and building better business models to meet it, and our industry is facing a significant paradigm shift from volume to value. We think we’re uniquely positioned to help drug, device and personalized medicine companies make this transition.”
In the past two years, Dohmen had added a specialty pharmaceuticals distributor (Centric Health), a medical devices distributor (Reglera) and two medical communications firms, BioSoteria and MedComm Solutions, to its existing businesses, DDN, a logistics services provider and a private investment group. Catamaran, meanwhile, styles itself as the fastest-growing PBM in the US, having been formed from the merger of SXC Health Solutions and Catalyst Health Solutions a year ago. The Lisle, IL, firm boasts 25 million members.
Understanding the FDA's Exemption for DSCSA Compliance
November 12th 2024In the quest for achieving full traceability, the exemption applies to certain trading partners under the Act, and postpones enforcement of final compliance requirements while acknowledging progress and ongoing challenges.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.